2018 Q4 Form 10-K Financial Statement

#000122460820000009 Filed on February 25, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $778.2M $1.481B $1.046B
YoY Change -28.61% 37.24% -1.02%
Cost Of Revenue $646.9M $618.2M
YoY Change 1.38% -2.52%
Gross Profit $834.3M $428.1M
YoY Change 89.1% 1.23%
Gross Profit Margin 56.33% 40.92%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $701.4M $1.982B $875.0M
YoY Change -24.52% 116.92% -2.47%
Operating Profit $109.0M $104.1M
YoY Change -123.06% -121.95%
Interest Expense -$39.70M $38.80M $37.70M
YoY Change 26.43% 28.9% 20.06%
% of Operating Profit 35.6% 36.22%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $37.10M -$539.8M $129.8M
YoY Change -70.41% -515.55% 1.01%
Income Tax $8.800M -$10.00M $27.60M
% Of Pretax Income 23.72% 21.26%
Net Earnings $28.30M -$529.8M $102.2M
YoY Change -139.92% -625.6% 22.54%
Net Earnings / Revenue 3.64% -35.77% 9.77%
Basic Earnings Per Share $0.17 -$3.22 $0.62
Diluted Earnings Per Share $0.17 -$3.22 $0.61
COMMON SHARES
Basic Shares Outstanding 164.6M shares 164.6M shares 166.1M shares
Diluted Shares Outstanding 164.6M shares 168.0M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $656.6M $595.6M $745.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $23.00B $23.36B $26.96B
YoY Change -17.44% -13.68% 0.28%
Other Assets $630.0M $578.0M $485.0M
YoY Change 71.66% 1.94% -18.35%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $31.44B $31.65B $32.47B
YoY Change -5.05% -3.23% -1.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $3.980B $3.980B $3.980B
YoY Change 0.2% 5.85% -2.78%
Other Long-Term Liabilities $632.0M $690.0M $654.0M
YoY Change -15.96% -12.55% -24.57%
Total Long-Term Liabilities $4.612B $4.670B $4.634B
YoY Change -2.37% 2.66% -6.59%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $4.612B $4.670B $4.634B
Total Liabilities $28.07B $28.03B $28.02B
YoY Change -0.69% 0.73% -0.16%
SHAREHOLDERS EQUITY
Retained Earnings $196.6M $184.8M $731.2M
YoY Change -64.92% -78.31% -4.59%
Common Stock $2.997B $3.032B $3.024B
YoY Change -2.55% -2.09% -3.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.371B $3.620B $4.455B
YoY Change
Total Liabilities & Shareholders Equity $31.44B $31.65B $32.47B
YoY Change -5.05% -3.23% -1.13%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income $28.30M -$529.8M $102.2M
YoY Change -139.92% -625.6% 22.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $202.8M -$128.7M $171.5M
YoY Change 10.34% -178.72% 20.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$211.1M -$73.70M -$142.8M
YoY Change -60.49% -175.44% -340.4%
Cash From Investing Activities -$211.1M -$73.70M -$142.8M
YoY Change -60.49% -175.44% -340.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 69.30M 52.30M -9.400M
YoY Change -70.64% -115.88% -93.6%
NET CHANGE
Cash From Operating Activities 202.8M -128.7M 171.5M
Cash From Investing Activities -211.1M -73.70M -142.8M
Cash From Financing Activities 69.30M 52.30M -9.400M
Net Change In Cash 61.00M -150.1M 19.30M
YoY Change -153.28% 120.41% -65.04%
FREE CASH FLOW
Cash From Operating Activities $202.8M -$128.7M $171.5M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 cno Investments In Upstream Affiliates Included In Statutory Capital And Surplus
InvestmentsInUpstreamAffiliatesIncludedInStatutoryCapitalAndSurplus
42600000 USD
CY2017 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax
1200000 USD
CY2018 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax
-300000 USD
CY2019 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax
-100000 USD
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001224608
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162201692 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148084178 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162201692 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148084178 shares
CY2018Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
319800000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
44200000 USD
CY2017 us-gaap Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits
InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits
0.05
CY2018 us-gaap Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits
InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits
0.05
CY2019 us-gaap Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits
InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits
0.05
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
194400000 USD
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-281300000 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
331100000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-31792
CY2019 dei Entity Registrant Name
EntityRegistrantName
CNO Financial Group, Inc.
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-3108137
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
11825 N. Pennsylvania Street
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Carmel,
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46032
CY2019 dei City Area Code
CityAreaCode
(317)
CY2019 dei Local Phone Number
LocalPhoneNumber
 817-6100
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
2600000000 USD
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146280557 shares
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21295200000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18447700000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
44100000 USD
CY2018Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
291000000.0 USD
CY2019Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
1566100000 USD
CY2018Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
1602100000 USD
CY2019Q4 us-gaap Policy Loans Receivable
PolicyLoansReceivable
124500000 USD
CY2018Q4 us-gaap Policy Loans Receivable
PolicyLoansReceivable
119700000 USD
CY2019Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
243900000 USD
CY2018Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
233100000 USD
CY2019Q4 cno Investments Held By Variable Interest Entities
InvestmentsHeldByVariableInterestEntities
1188600000 USD
CY2018Q4 cno Investments Held By Variable Interest Entities
InvestmentsHeldByVariableInterestEntities
1468400000 USD
CY2019Q4 us-gaap Other Investments
OtherInvestments
1118500000 USD
CY2018Q4 us-gaap Other Investments
OtherInvestments
833400000 USD
CY2019Q4 us-gaap Investments
Investments
25580900000 USD
CY2018Q4 us-gaap Investments
Investments
22995400000 USD
CY2019Q4 cno Cashandcashequivalentsunrestricted
Cashandcashequivalentsunrestricted
580000000.0 USD
CY2018Q4 cno Cashandcashequivalentsunrestricted
Cashandcashequivalentsunrestricted
594200000 USD
CY2019Q4 cno Cash And Cash Equivalents Held By Variable Interest Entities
CashAndCashEquivalentsHeldByVariableInterestEntities
74700000 USD
CY2018Q4 cno Cash And Cash Equivalents Held By Variable Interest Entities
CashAndCashEquivalentsHeldByVariableInterestEntities
62400000 USD
CY2019Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
205900000 USD
CY2018Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
205200000 USD
CY2019Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
275400000 USD
CY2018Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
343600000 USD
CY2019Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1215500000 USD
CY2018Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1322500000 USD
CY2019Q4 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
4785700000 USD
CY2018Q4 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
4925400000 USD
CY2019Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
432600000 USD
CY2018Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
630000000.0 USD
CY2019Q4 us-gaap Separate Account Assets
SeparateAccountAssets
4200000 USD
CY2018Q4 us-gaap Separate Account Assets
SeparateAccountAssets
4400000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
476000000.0 USD
CY2018Q4 us-gaap Other Assets
OtherAssets
356700000 USD
CY2019Q4 us-gaap Assets
Assets
33630900000 USD
CY2018Q4 us-gaap Assets
Assets
31439800000 USD
CY2019Q4 cno Liabilities For Interest Sensitive Products
LiabilitiesForInterestSensitiveProducts
12132300000 USD
CY2018Q4 cno Liabilities For Interest Sensitive Products
LiabilitiesForInterestSensitiveProducts
11522800000 USD
CY2019Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11498500000 USD
CY2018Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11153700000 USD
CY2019Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
522300000 USD
CY2018Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
521900000 USD
CY2019Q4 us-gaap Unearned Premiums
UnearnedPremiums
260500000 USD
CY2018Q4 us-gaap Unearned Premiums
UnearnedPremiums
253900000 USD
CY2019Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
4200000 USD
CY2018Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
4400000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
750200000 USD
CY2018Q4 us-gaap Other Liabilities
OtherLiabilities
632400000 USD
CY2019Q4 cno Investment Borrowings
InvestmentBorrowings
1644300000 USD
CY2018Q4 cno Investment Borrowings
InvestmentBorrowings
1645800000 USD
CY2019Q4 cno Borrowings Related To Variable Interest Entities
BorrowingsRelatedToVariableInterestEntities
1152500000 USD
CY2018Q4 cno Borrowings Related To Variable Interest Entities
BorrowingsRelatedToVariableInterestEntities
1417200000 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
989100000 USD
CY2018Q4 us-gaap Notes Payable
NotesPayable
916800000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
28953900000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
28068900000 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1500000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1600000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2767300000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2995000000.0 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1372500000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
177700000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
535700000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
196600000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4677000000.0 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3370900000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33630900000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31439800000 USD
CY2019 us-gaap Premiums Earned Net
PremiumsEarnedNet
2480800000 USD
CY2018 us-gaap Premiums Earned Net
PremiumsEarnedNet
2593100000 USD
CY2017 us-gaap Premiums Earned Net
PremiumsEarnedNet
2647300000 USD
CY2019 cno Net Investment Income On General Account Invested Assets
NetInvestmentIncomeOnGeneralAccountInvestedAssets
1105200000 USD
CY2018 cno Net Investment Income On General Account Invested Assets
NetInvestmentIncomeOnGeneralAccountInvestedAssets
1279700000 USD
CY2017 cno Net Investment Income On General Account Invested Assets
NetInvestmentIncomeOnGeneralAccountInvestedAssets
1285400000 USD
CY2019 cno Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios
NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios
257700000 USD
CY2018 cno Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios
NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios
26500000 USD
CY2017 cno Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios
NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios
265900000 USD
CY2019 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
0 USD
CY2018 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
363400000 USD
CY2017 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
0 USD
CY2019 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
40600000 USD
CY2018 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-8700000 USD
CY2017 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
77400000 USD
CY2019 us-gaap Impairment Of Investments
ImpairmentOfInvestments
12400000 USD
CY2018 us-gaap Impairment Of Investments
ImpairmentOfInvestments
2600000 USD
CY2017 us-gaap Impairment Of Investments
ImpairmentOfInvestments
21900000 USD
CY2019 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
0 USD
CY2018 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
0 USD
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
-900000 USD
CY2019 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
12400000 USD
CY2018 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
2600000 USD
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
22800000 USD
CY2019 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
0 USD
CY2018 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
0 USD
CY2017 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
-4300000 USD
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
28200000 USD
CY2018 us-gaap Gain Loss On Investments
GainLossOnInvestments
352100000 USD
CY2017 us-gaap Gain Loss On Investments
GainLossOnInvestments
50300000 USD
CY2019 cno Fee Revenue And Other Income
FeeRevenueAndOtherIncome
143900000 USD
CY2018 cno Fee Revenue And Other Income
FeeRevenueAndOtherIncome
62100000 USD
CY2017 cno Fee Revenue And Other Income
FeeRevenueAndOtherIncome
48300000 USD
CY2019 us-gaap Revenues
Revenues
4015800000 USD
CY2018 us-gaap Revenues
Revenues
4313500000 USD
CY2017 us-gaap Revenues
Revenues
4297200000 USD
CY2019 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2417000000.0 USD
CY2018 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2278600000 USD
CY2017 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2602700000 USD
CY2019 cno Loss Related To Reinsurance Transaction
LossRelatedToReinsuranceTransaction
0 USD
CY2018 cno Loss Related To Reinsurance Transaction
LossRelatedToReinsuranceTransaction
-1067600000 USD
CY2017 cno Loss Related To Reinsurance Transaction
LossRelatedToReinsuranceTransaction
0 USD
CY2019 us-gaap Interest Expense
InterestExpense
152300000 USD
CY2018 us-gaap Interest Expense
InterestExpense
149800000 USD
CY2017 us-gaap Interest Expense
InterestExpense
123700000 USD
CY2019 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
232100000 USD
CY2018 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
264300000 USD
CY2017 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
239300000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7300000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019 cno Gain Loss On Extinguishment Of Debt Variable Interest Entities
GainLossOnExtinguishmentOfDebtVariableInterestEntities
0 USD
CY2018 cno Gain Loss On Extinguishment Of Debt Variable Interest Entities
GainLossOnExtinguishmentOfDebtVariableInterestEntities
-3800000 USD
CY2017 cno Gain Loss On Extinguishment Of Debt Variable Interest Entities
GainLossOnExtinguishmentOfDebtVariableInterestEntities
-9500000 USD
CY2019 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
932900000 USD
CY2018 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
814200000 USD
CY2017 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
841500000 USD
CY2019 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
3741600000 USD
CY2018 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
4578300000 USD
CY2017 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
3816700000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
274200000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-264800000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
480500000 USD
CY2019 cno Income Tax Expense Benefit Before Valuation Allowance Adjustment
IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment
58500000 USD
CY2018 cno Income Tax Expense Benefit Before Valuation Allowance Adjustment
IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment
-57600000 USD
CY2017 cno Income Tax Expense Benefit Before Valuation Allowance Adjustment
IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment
162800000 USD
CY2019 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-193700000 USD
CY2018 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
107800000 USD
CY2017 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
142100000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
409400000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-315000000.0 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156040000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165457000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170025000 shares
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.62
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157148000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165457000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172144000 shares
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.61
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2019 us-gaap Net Income Loss
NetIncomeLoss
409400000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-315000000.0 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1830200000 USD
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1579900000 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
959300000 USD
CY2019 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax
165600000 USD
CY2018 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax
-125500000 USD
CY2017 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax
29700000 USD
CY2019 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax
-133000000.0 USD
CY2018 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax
512000000.0 USD
CY2017 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax
-310500000 USD
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
6300000 USD
CY2018 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
356900000 USD
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
40200000 USD
CY2019 cno Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax
600000 USD
CY2018 cno Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax
-400000 USD
CY2017 cno Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax
1000000.0 USD
CY2019 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1525900000 USD
CY2018 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-1299700000 USD
CY2017 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
579900000 USD
CY2019 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
331100000 USD
CY2018 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-281600000 USD
CY2017 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
195600000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1194800000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1018100000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
384300000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1604200000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1333100000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
559900000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
4486900000 USD
CY2017Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
300000 USD
CY2017Q1 cno Stockholders Equity Attributableto Parent Adjusted Balance
StockholdersEquityAttributabletoParentAdjustedBalance
4487200000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
382100000 USD
CY2017 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale
2200000 USD
CY2017 us-gaap Tax Cuts And Jobs Act Of2017 Reclassification From Aoci To Retained Earnings Tax Effect
TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
0 USD
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
167100000 USD
CY2017 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
59900000 USD
CY2017 cno Stock Based Compensation
StockBasedCompensation
27400000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4847500000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
0 USD
CY2018Q1 cno Stockholders Equity Attributableto Parent Adjusted Balance
StockholdersEquityAttributabletoParentAdjustedBalance
4847500000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-315000000.0 USD
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1017000000.0 USD
CY2018 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale
-1100000 USD
CY2018 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
100900000 USD
CY2018 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
65100000 USD
CY2018 cno Stock Based Compensation
StockBasedCompensation
22500000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3370900000 USD
CY2019Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-3100000 USD
CY2019Q1 cno Stockholders Equity Attributableto Parent Adjusted Balance
StockholdersEquityAttributabletoParentAdjustedBalance
3367800000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
409400000 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1194900000 USD
CY2019 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale
-100000 USD
CY2019 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
252300000 USD
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
67200000 USD
CY2019 cno Stock Based Compensation
StockBasedCompensation
24500000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4677000000.0 USD
CY2019 us-gaap Proceeds From Insurance Premiums Collected
ProceedsFromInsurancePremiumsCollected
2326000000.0 USD
CY2018 us-gaap Proceeds From Insurance Premiums Collected
ProceedsFromInsurancePremiumsCollected
2433400000 USD
CY2017 us-gaap Proceeds From Insurance Premiums Collected
ProceedsFromInsurancePremiumsCollected
2483200000 USD
CY2019 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1122300000 USD
CY2018 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1321200000 USD
CY2017 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1256300000 USD
CY2019 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
132600000 USD
CY2018 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
62100000 USD
CY2017 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
48300000 USD
CY2019 cno Insurance Policy Benefits
InsurancePolicyBenefits
1630100000 USD
CY2018 cno Insurance Policy Benefits
InsurancePolicyBenefits
1910700000 USD
CY2017 cno Insurance Policy Benefits
InsurancePolicyBenefits
1973100000 USD
CY2019 cno Payment To Reinsurer Pursuant To Long Term Care Business Reinsured
PaymentToReinsurerPursuantToLongTermCareBusinessReinsured
0 USD
CY2018 cno Payment To Reinsurer Pursuant To Long Term Care Business Reinsured
PaymentToReinsurerPursuantToLongTermCareBusinessReinsured
365000000.0 USD
CY2017 cno Payment To Reinsurer Pursuant To Long Term Care Business Reinsured
PaymentToReinsurerPursuantToLongTermCareBusinessReinsured
0 USD
CY2019 us-gaap Interest Paid
InterestPaid
151200000 USD
CY2018 us-gaap Interest Paid
InterestPaid
141100000 USD
CY2017 us-gaap Interest Paid
InterestPaid
120500000 USD
CY2019 cno Policy Acquisition Costs
PolicyAcquisitionCosts
288700000 USD
CY2018 cno Policy Acquisition Costs
PolicyAcquisitionCosts
261800000 USD
CY2017 cno Policy Acquisition Costs
PolicyAcquisitionCosts
236100000 USD
CY2019 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
816600000 USD
CY2018 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
788500000 USD
CY2017 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
747400000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2400000 USD
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
31800000 USD
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
77400000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
696700000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
317800000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
633300000 USD
CY2019 cno Sales Of Investments
SalesOfInvestments
2899200000 USD
CY2018 cno Sales Of Investments
SalesOfInvestments
3210200000 USD
CY2017 cno Sales Of Investments
SalesOfInvestments
2460700000 USD
CY2019 cno Maturities And Redemptions Of Investments
MaturitiesAndRedemptionsOfInvestments
2237700000 USD
CY2018 cno Maturities And Redemptions Of Investments
MaturitiesAndRedemptionsOfInvestments
2469000000.0 USD
CY2017 cno Maturities And Redemptions Of Investments
MaturitiesAndRedemptionsOfInvestments
3324600000 USD
CY2019 cno Purchases Of Investments
PurchasesOfInvestments
5576400000 USD
CY2018 cno Purchases Of Investments
PurchasesOfInvestments
6205800000 USD
CY2017 cno Purchases Of Investments
PurchasesOfInvestments
6141000000.0 USD
CY2019 cno Net Sales Of Trading Securities
NetSalesOfTradingSecurities
14100000 USD
CY2018 cno Net Sales Of Trading Securities
NetSalesOfTradingSecurities
-25900000 USD
CY2017 cno Net Sales Of Trading Securities
NetSalesOfTradingSecurities
-108900000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
102000000.0 USD
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
25000000.0 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
23400000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-555600000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-525700000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-270200000 USD
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
494200000 USD
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
425000000.0 USD
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2019 cno Expenses Related To Debt Modification And Extinguishment Of Debt
ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt
6100000 USD
CY2018 cno Expenses Related To Debt Modification And Extinguishment Of Debt
ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt
0 USD
CY2017 cno Expenses Related To Debt Modification And Extinguishment Of Debt
ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt
0 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9200000 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3900000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8300000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
254500000 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
108000000.0 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
168300000 USD
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
67100000 USD
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
64800000 USD
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
59600000 USD
CY2019 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
1743100000 USD
CY2018 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
1588500000 USD
CY2017 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
1445900000 USD
CY2019 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
1363900000 USD
CY2018 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
1312300000 USD
CY2017 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
1232600000 USD
CY2019 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
536800000 USD
CY2018 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
150000000.0 USD
CY2017 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
432000000.0 USD
CY2019 cno Proceeds From Investment Borrowings Related To Variable Interest Entities
ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities
0 USD
CY2018 cno Proceeds From Investment Borrowings Related To Variable Interest Entities
ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities
277600000 USD
CY2017 cno Proceeds From Investment Borrowings Related To Variable Interest Entities
ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities
981600000 USD
CY2019 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
538200000 USD
CY2018 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
150900000 USD
CY2017 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
432700000 USD
CY2019 cno Repayments Of Investment Borrowings Related To Variable Interest Entities
RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities
271500000 USD
CY2018 cno Repayments Of Investment Borrowings Related To Variable Interest Entities
RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities
276800000 USD
CY2017 cno Repayments Of Investment Borrowings Related To Variable Interest Entities
RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities
1248600000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-143000000.0 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
107200000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-274000000.0 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1900000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-100700000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89100000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
656600000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
757300000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
668200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
654700000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
656600000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
757300000 USD
CY2019 cno Number Of Product Distribution Channels
NumberOfProductDistributionChannels
3 distribution_channel
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals.  If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.</span></div>
CY2019 cno Discount Rate Used To Determine Present Value Of Future Insurance Profits
DiscountRateUsedToDeterminePresentValueOfFutureInsuranceProfits
0.12
CY2019 us-gaap Ceded Premiums Written
CededPremiumsWritten
260600000 USD
CY2018 us-gaap Ceded Premiums Written
CededPremiumsWritten
144500000 USD
CY2017 us-gaap Ceded Premiums Written
CededPremiumsWritten
105000000.0 USD
CY2019 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
439800000 USD
CY2018 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
173500000 USD
CY2017 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
88600000 USD
CY2019 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
25100000 USD
CY2018 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
28000000.0 USD
CY2017 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
30400000 USD
CY2019 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Assumed
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
36400000 USD
CY2017 us-gaap Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
8900000 USD
CY2019Q4 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
60700000 USD
CY2018 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Assumed
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
36400000 USD
CY2017 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Assumed
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
44700000 USD
CY2018Q3 cno Statutory Liabilities Transferred Reinsurance Transaction
StatutoryLiabilitiesTransferredReinsuranceTransaction
2700000000 USD
CY2018Q3 cno Negativecedingcommission
Negativecedingcommission
825000000 USD
CY2018Q3 cno Reinsurance Transaction After Tax Charge
ReinsuranceTransactionAfterTaxCharge
661100000 USD
CY2018Q3 cno Trust Account Assets Amountof Over Collateralization
TrustAccountAssetsAmountofOverCollateralization
500000000 USD
CY2019Q4 cno Investments Held In Limited Partnerships
InvestmentsHeldInLimitedPartnerships
578200000 USD
CY2019Q4 cno Unfunded Commitmentsto Limited Partnerships
UnfundedCommitmentstoLimitedPartnerships
102300000 USD
CY2019 cno Insurance Subsidiaries
InsuranceSubsidiaries
3 subsidiary
CY2019 cno Interest Expense On Fhlb Borrowings
InterestExpenseOnFhlbBorrowings
46200000 USD
CY2018 cno Interest Expense On Fhlb Borrowings
InterestExpenseOnFhlbBorrowings
41900000 USD
CY2017 cno Interest Expense On Fhlb Borrowings
InterestExpenseOnFhlbBorrowings
27000000.0 USD
CY2019 us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting for Derivatives</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard &amp; Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. We are required to record the embedded derivatives related to our fixed index annuity products at estimated fair value. </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The value of the embedded derivative is based on the estimated cost to fulfill our commitment to fixed indexed annuity policyholders to purchase a series of annual forward options over the duration of the policy that back the potential return based on a percentage of the amount of increase in the value of the appropriate index. In valuing these options, we are required to make assumptions regarding: (i) future index values to determine both the future notional amounts at each anniversary date and the future prices of the forward starting options; (ii) future annual participation rates; and (iii) non-economic factors related to policy persistency. These assumptions are used to estimate the future cost to purchase the options.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The value of the embedded derivatives is determined based on the present value of estimated future option costs discounted using a risk-free rate adjusted for our non-performance risk and risk margins for non-capital market inputs. The non-performance risk adjustment is determined by taking into consideration publicly available information related to spreads in the secondary market for debt with credit ratings similar to ours. These observable spreads are then adjusted to reflect the priority of these liabilities and the claim paying ability of the issuing insurance subsidiaries.</span></div><div style="line-height:120%;text-align:left;padding-left:60px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Risk margins are established to capture non-capital market risks which represent the additional compensation a market participant would require to assume the risks related to the uncertainties regarding the embedded derivatives, including future policyholder behavior related to persistency. The determination of the risk margin is highly judgmental given the lack of a market to assume the risks solely related to the embedded derivatives of our fixed index annuity products.</span></div><div style="line-height:120%;text-align:left;padding-left:60px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The determination of the appropriate risk-free rate and non-performance risk is sensitive to the economic and interest rate environment. Accordingly, the value of the derivative is volatile due to external market sensitivities, which may materially affect net income. Additionally, changes in the judgmental assumptions regarding the appropriate risk margin can significantly impact the value of the derivative.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.</span></div>
CY2019 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
24900000 USD
CY2018 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
11600000 USD
CY2017 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
2000000.0 USD
CY2019 us-gaap Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
7700000 USD
CY2018 us-gaap Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
10600000 USD
CY2018Q4 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
43500000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18443700000 USD
CY2019Q1 cno Deferred Income Tax Assets Net Including Netof Current Income Tax Payable
DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable
630900000 USD
CY2019Q1 us-gaap Assets
Assets
31436700000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
193500000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
3367800000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1195800000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
576700000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
4847500000 USD
CY2017 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1256300000 USD
CY2017 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
747400000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
633300000 USD
CY2017 cno Sales Of Investments
SalesOfInvestments
2460700000 USD
CY2017 cno Change In Cash And Cash Equivalents Held By Variable Interest Entities
ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities
0 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
23400000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-270200000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89100000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
668200000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
757300000 USD
CY2017Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1045900000 USD
CY2017Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
255900000 USD
CY2017Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
790000000.0 USD
CY2017Q1 us-gaap Assets
Assets
31975500000 USD
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3213000000.0 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
650100000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
4487200000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31975500000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
19179500000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2136800000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
21100000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21295200000 USD
CY2019 cno Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss
AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss
300000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
19179500000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21295200000 USD
CY2019Q4 cno Available For Sale Securities Fair Value Disclosure Percentage Of Estimated Fair Value
AvailableForSaleSecuritiesFairValueDisclosurePercentageOfEstimatedFairValue
1.000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18107800000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
763200000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
423300000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18447700000 USD
CY2018 cno Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss
AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss
500000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized
1100000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized
1200000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments
2095300000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments
271300000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits
AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits
-18900000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits
AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits
-4500000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs
AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts
-227900000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs
AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts
-38300000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-96500000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-2500000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities
AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities
-380600000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities
AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities
-49500000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1372500000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
177700000 USD
CY2019Q4 cno Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-12200000 USD
CY2019Q4 cno Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-26800000 USD
CY2019Q4 cno Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-96500000 USD
CY2019Q4 cno Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
29400000 USD
CY2018Q4 cno Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-2500000 USD
CY2018Q4 cno Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
500000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
282200000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
286000000.0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1082200000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1130800000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1376600000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1481700000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
10908600000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
12583700000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities
13649600000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities
AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities
15482200000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
5529900000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
5813000000.0 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
19179500000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21295200000 USD
CY2019 cno Gross Investment Income Insurance Entity Fixed Maturities
GrossInvestmentIncomeInsuranceEntityFixedMaturities
952400000 USD
CY2018 cno Gross Investment Income Insurance Entity Fixed Maturities
GrossInvestmentIncomeInsuranceEntityFixedMaturities
1100300000 USD
CY2017 cno Gross Investment Income Insurance Entity Fixed Maturities
GrossInvestmentIncomeInsuranceEntityFixedMaturities
1133800000 USD
CY2019 cno Gross Investment Income Insurance Entity Equity Securities
GrossInvestmentIncomeInsuranceEntityEquitySecurities
3200000 USD
CY2018 cno Gross Investment Income Insurance Entity Equity Securities
GrossInvestmentIncomeInsuranceEntityEquitySecurities
22800000 USD
CY2017 cno Gross Investment Income Insurance Entity Equity Securities
GrossInvestmentIncomeInsuranceEntityEquitySecurities
22500000 USD
CY2019 cno Gross Investment Income Insurance Entity Mortgage Loans On Real Estate
GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate
77100000 USD
CY2018 cno Gross Investment Income Insurance Entity Mortgage Loans On Real Estate
GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate
82000000.0 USD
CY2017 cno Gross Investment Income Insurance Entity Mortgage Loans On Real Estate
GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate
91500000 USD
CY2019 cno Gross Investment Income Insurance Entity Policy Loans
GrossInvestmentIncomeInsuranceEntityPolicyLoans
8300000 USD
CY2018 cno Gross Investment Income Insurance Entity Policy Loans
GrossInvestmentIncomeInsuranceEntityPolicyLoans
8000000.0 USD
CY2017 cno Gross Investment Income Insurance Entity Policy Loans
GrossInvestmentIncomeInsuranceEntityPolicyLoans
7700000 USD
CY2019 cno Gross Investment Income Insurance Entity Other Invested Assets
GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets
72500000 USD
CY2018 cno Gross Investment Income Insurance Entity Other Invested Assets
GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets
79200000 USD
CY2017 cno Gross Investment Income Insurance Entity Other Invested Assets
GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets
47200000 USD
CY2019 cno Gross Investment Income Insurance Entity Cash And Cash Equivalents
GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents
13300000 USD
CY2018 cno Gross Investment Income Insurance Entity Cash And Cash Equivalents
GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents
10900000 USD
CY2017 cno Gross Investment Income Insurance Entity Cash And Cash Equivalents
GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents
5900000 USD
CY2019 cno Gross Investment Income Insurance Entity Trading Securities
GrossInvestmentIncomeInsuranceEntityTradingSecurities
8900000 USD
CY2018 cno Gross Investment Income Insurance Entity Trading Securities
GrossInvestmentIncomeInsuranceEntityTradingSecurities
8500000 USD
CY2017 cno Gross Investment Income Insurance Entity Trading Securities
GrossInvestmentIncomeInsuranceEntityTradingSecurities
12800000 USD
CY2019 cno Gross Investment Income Insurance Entity Option Income Loss
GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss
-21200000 USD
CY2018 cno Gross Investment Income Insurance Entity Option Income Loss
GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss
122300000 USD
CY2017 cno Gross Investment Income Insurance Entity Option Income Loss
GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss
110300000 USD
CY2019 cno Gross Investment Income Insurance Entity Increase Decrease In Value Of Options
GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions
173100000 USD
CY2018 cno Gross Investment Income Insurance Entity Increase Decrease In Value Of Options
GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions
-165300000 USD
CY2017 cno Gross Investment Income Insurance Entity Increase Decrease In Value Of Options
GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions
52200000 USD
CY2019 cno Gross Investment Income Insurance Entity Other Specialpurpose Portfolios
GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios
96900000 USD
CY2018 cno Gross Investment Income Insurance Entity Other Specialpurpose Portfolios
GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios
61000000.0 USD
CY2017 cno Gross Investment Income Insurance Entity Other Specialpurpose Portfolios
GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios
90600000 USD
CY2019 cno Gross Investment Income Insurance Entity
GrossInvestmentIncomeInsuranceEntity
1384500000 USD
CY2018 cno Gross Investment Income Insurance Entity
GrossInvestmentIncomeInsuranceEntity
1329700000 USD
CY2017 cno Gross Investment Income Insurance Entity
GrossInvestmentIncomeInsuranceEntity
1574500000 USD
CY2019 cno Investment Income Insurance Entity Investment Expense
InvestmentIncomeInsuranceEntityInvestmentExpense
21600000 USD
CY2018 cno Investment Income Insurance Entity Investment Expense
InvestmentIncomeInsuranceEntityInvestmentExpense
23500000 USD
CY2017 cno Investment Income Insurance Entity Investment Expense
InvestmentIncomeInsuranceEntityInvestmentExpense
23200000 USD
CY2019 us-gaap Net Investment Income
NetInvestmentIncome
1362900000 USD
CY2018 us-gaap Net Investment Income
NetInvestmentIncome
1306200000 USD
CY2017 us-gaap Net Investment Income
NetInvestmentIncome
1551300000 USD
CY2019Q4 cno Carrying Value Of Fixed Maturity Investments Not Accruing Investment Income
CarryingValueOfFixedMaturityInvestmentsNotAccruingInvestmentIncome
1000000.0 USD
CY2019Q4 cno Carrying Value Mortgage Loans Not Accruing Investment Income
CarryingValueMortgageLoansNotAccruingInvestmentIncome
5900000 USD
CY2019 cno Variable Interest Entity Realized Gain Loss On Sale Of Investments Related To Dissolution
VariableInterestEntityRealizedGainLossOnSaleOfInvestmentsRelatedToDissolution
-5100000 USD
CY2018 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
0 USD
CY2017 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
-4300000 USD
CY2019 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
0 USD
CY2018 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
363400000 USD
CY2017 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
0 USD
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
28200000 USD
CY2018 us-gaap Gain Loss On Investments
GainLossOnInvestments
352100000 USD
CY2017 us-gaap Gain Loss On Investments
GainLossOnInvestments
50300000 USD
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
28200000 USD
CY2019 cno Variable Interest Entity Realized Gain Loss On Sale Of Investments Related To Dissolution
VariableInterestEntityRealizedGainLossOnSaleOfInvestmentsRelatedToDissolution
-5100000 USD
CY2019 us-gaap Impairment Of Investments
ImpairmentOfInvestments
12400000 USD
CY2019 cno Variable Interest Entity Realized Gain Loss On Sale Of Investments Related To Dissolution
VariableInterestEntityRealizedGainLossOnSaleOfInvestmentsRelatedToDissolution
-5100000 USD
CY2017 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
-4300000 USD
CY2018 us-gaap Gain Loss On Investments
GainLossOnInvestments
352100000 USD
CY2018 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
363400000 USD
CY2018 us-gaap Impairment Of Investments
ImpairmentOfInvestments
2600000 USD
CY2017 us-gaap Gain Loss On Investments
GainLossOnInvestments
50300000 USD
CY2017 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
-4300000 USD
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
22800000 USD
CY2019Q4 cno Numberof Investmentsin Defaultor Considered Nonperforming
NumberofInvestmentsinDefaultorConsideredNonperforming
0 investment
CY2019 cno Available For Sale Securities Value Of Securities Sold
AvailableForSaleSecuritiesValueOfSecuritiesSold
971200000 USD
CY2019 us-gaap Impairment Of Investments
ImpairmentOfInvestments
12400000 USD
CY2018 cno Available For Sale Securities Value Of Securities Sold
AvailableForSaleSecuritiesValueOfSecuritiesSold
1295800000 USD
CY2018 us-gaap Impairment Of Investments
ImpairmentOfInvestments
2600000 USD
CY2017 cno Available For Sale Securities Value Of Securities Sold
AvailableForSaleSecuritiesValueOfSecuritiesSold
427600000 USD
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
22800000 USD
CY2017 cno Other Than Temporary Impairment Losses Losseson Other Investments Following Unforeseen Events
OtherThanTemporaryImpairmentLossesLossesonOtherInvestmentsFollowingUnforeseenEvents
10900000 USD
CY2019 cno Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss
AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss
300000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Within One Year Amortized Cost Basis With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCostBasisWithUnrealizedLosses
2800000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Within One Year Fair Value With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueWithUnrealizedLosses
2800000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Basis With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCostBasisWithUnrealizedLosses
8700000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities After One Through Five Years Fair Value With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValueWithUnrealizedLosses
8600000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Basis With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCostBasisWithUnrealizedLosses
25500000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValueWithUnrealizedLosses
24400000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities After Ten Years Amortized Cost Basis With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCostBasisWithUnrealizedLosses
503200000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities After Ten Years Fair Value With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValueWithUnrealizedLosses
490500000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Amortized Cost With Unrealized Losses Subtotal
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostWithUnrealizedLossesSubtotal
540200000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Subtotal
AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesSubtotal
526300000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost Basis With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCostBasisWithUnrealizedLosses
1084900000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value With Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValueWithUnrealizedLosses
1077700000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Amortized Cost Basis With Unrealized Losses Total
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisWithUnrealizedLossesTotal
1625100000 USD
CY2019Q4 cno Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Total
AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesTotal
1604000000.0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1262800000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
11400000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
341200000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
9700000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1604000000.0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
21100000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
6310700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
308600000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1465000000.0 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
114700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
7775700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
423300000 USD
CY2019Q4 cno Available For Sale Securities Structured Securities Fair Value
AvailableForSaleSecuritiesStructuredSecuritiesFairValue
5800000000 USD
CY2019Q4 cno Available For Sale Securities Structured Securities Fair Value Percentage Of All Fixed Maturity Securities
AvailableForSaleSecuritiesStructuredSecuritiesFairValuePercentageOfAllFixedMaturitySecurities
0.273
CY2019Q4 cno Available For Sale Securities Structured Securities Amortized Cost Basis
AvailableForSaleSecuritiesStructuredSecuritiesAmortizedCostBasis
5529900000 USD
CY2019Q4 cno Available For Sale Securities Structured Securities Fair Value
AvailableForSaleSecuritiesStructuredSecuritiesFairValue
5813000000.0 USD
CY2019Q4 cno Available For Sale Securities Structured Securities Fair Value Percentage Of All Fixed Maturity Securities
AvailableForSaleSecuritiesStructuredSecuritiesFairValuePercentageOfAllFixedMaturitySecurities
0.273
CY2019Q4 cno Number Of Additional States Greater Than Specified Percentage Of Mortgage Loan Balance
NumberOfAdditionalStatesGreaterThanSpecifiedPercentageOfMortgageLoanBalance
0 state
CY2019 cno Numberof Mortgage Loansin Processof Foreclosure
NumberofMortgageLoansinProcessofForeclosure
1 Loan
CY2019Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
5900000 USD
CY2019Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
39600000 USD
CY2018Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
39000000.0 USD
CY2019 cno Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage
FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage
0.22
CY2019Q4 cno Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent
AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent
0.86
CY2019Q4 cno Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent
AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent
0.93
CY2019Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11498500000 USD
CY2018Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11153700000 USD
CY2019Q4 us-gaap Policyholder Contract Deposits
PolicyholderContractDeposits
12132300000 USD
CY2018Q4 us-gaap Policyholder Contract Deposits
PolicyholderContractDeposits
11522800000 USD
CY2019 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in the unpaid claims reserve (included in claims payable) and disabled life reserves related to accident and health insurance (included in the liability for future policy benefits) were as follows (dollars in millions):</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.07602339181285%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,868.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,828.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,777.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less reinsurance (receivables) payables</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(951.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net balance, beginning of year</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>916.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,843.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,791.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incurred claims related to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,233.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,480.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,548.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior years (a)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(41.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total incurred</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,193.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,438.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,521.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest on claim reserves</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Paid claims related to:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(843.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(849.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(845.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior years</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(374.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(630.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(702.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total paid</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,218.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,480.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,548.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reserves ceded pursuant to reinsurance transaction</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(956.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net balance, end of year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>928.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>916.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,843.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add reinsurance receivables (payables)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>993.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,921.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,868.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,828.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">___________</span></div><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The reserves and liabilities we establish are necessarily based on estimates, assumptions and prior years' statistics. Such amounts will fluctuate based upon the estimation procedures used to determine the amount of unpaid losses. It is possible that actual claims will exceed our reserves and have a material adverse effect on our results of operations and financial condition.</span></div>
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
19200000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-2800000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
90800000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
39300000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
93100000 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000000.0 USD
CY2019 cno Income Tax Expense Benefit Current Valuation Allowance
IncomeTaxExpenseBenefitCurrentValuationAllowance
0 USD
CY2018 cno Income Tax Expense Benefit Current Valuation Allowance
IncomeTaxExpenseBenefitCurrentValuationAllowance
-8900000 USD
CY2017 cno Income Tax Expense Benefit Current Valuation Allowance
IncomeTaxExpenseBenefitCurrentValuationAllowance
15300000 USD
CY2019 cno Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate
IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate
58500000 USD
CY2018 cno Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate
IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate
99200000 USD
CY2017 cno Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate
IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate
147500000 USD
CY2019 cno Tax Benefit On Longterm Care Reinsurance Transaction
TaxBenefitOnLongtermCareReinsuranceTransaction
0 USD
CY2018 cno Tax Benefit On Longterm Care Reinsurance Transaction
TaxBenefitOnLongtermCareReinsuranceTransaction
147900000 USD
CY2017 cno Tax Benefit On Longterm Care Reinsurance Transaction
TaxBenefitOnLongtermCareReinsuranceTransaction
0 USD
CY2019 cno Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items
IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems
-193700000 USD
CY2018 cno Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items
IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems
95700000 USD
CY2017 cno Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items
IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems
-13400000 USD
CY2019 cno Income Tax Expense Benefit Impact Of Federal Tax Reform
IncomeTaxExpenseBenefitImpactOfFederalTaxReform
0 USD
CY2018 cno Income Tax Expense Benefit Impact Of Federal Tax Reform
IncomeTaxExpenseBenefitImpactOfFederalTaxReform
0 USD
CY2017 cno Income Tax Expense Benefit Impact Of Federal Tax Reform
IncomeTaxExpenseBenefitImpactOfFederalTaxReform
310600000 USD
CY2019 cno Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Valuation Allowance Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxValuationAllowanceProvisionalIncomeTaxExpenseBenefit
0 USD
CY2018 cno Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Valuation Allowance Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxValuationAllowanceProvisionalIncomeTaxExpenseBenefit
0 USD
CY2017 cno Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Valuation Allowance Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxValuationAllowanceProvisionalIncomeTaxExpenseBenefit
-138100000 USD
CY2019 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0 USD
CY2018 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
3200000 USD
CY2017 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-1700000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-135200000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50200000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
304900000 USD
CY2017 us-gaap Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
172500000 USD
CY2017 us-gaap Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
172500000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.706
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.395
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.060
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.010
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.006
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.020
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.011
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.647
CY2019 cno Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Change In Deferred Tax Asset Valuation Allowance
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017ChangeInDeferredTaxAssetValuationAllowance
0
CY2018 cno Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Change In Deferred Tax Asset Valuation Allowance
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017ChangeInDeferredTaxAssetValuationAllowance
0
CY2017 cno Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Change In Deferred Tax Asset Valuation Allowance
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017ChangeInDeferredTaxAssetValuationAllowance
-0.288
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.493
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.190
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.635
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
532300000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
685100000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
10300000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
14500000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities
351300000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities
283900000 USD
CY2019Q4 cno Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets
DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets
50300000 USD
CY2018Q4 cno Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets
DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
40400000 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
46300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
984600000 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1029800000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
24400000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
10100000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
150100000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
171100000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
381200000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
50200000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
555700000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
231400000 USD
CY2019Q4 cno Deferred Tax Assets Before Valuation Allowance
DeferredTaxAssetsBeforeValuationAllowance
428900000 USD
CY2018Q4 cno Deferred Tax Assets Before Valuation Allowance
DeferredTaxAssetsBeforeValuationAllowance
798400000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
193700000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
428900000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
604700000 USD
CY2019Q4 cno Prepaid Accrued Income Taxes Current
PrepaidAccruedIncomeTaxesCurrent
3700000 USD
CY2018Q4 cno Prepaid Accrued Income Taxes Current
PrepaidAccruedIncomeTaxesCurrent
25300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
432600000 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
630000000.0 USD
CY2019Q4 cno Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis
AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis
0.035
CY2019Q4 cno Deferred Tax Assets Before Valuation Allowance
DeferredTaxAssetsBeforeValuationAllowance
428900000 USD
CY2019Q4 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-193700000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
240200000 USD
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-166800000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
89100000 USD
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
104600000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
193700000 USD
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-193700000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2017 cno Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Valuation Allowance Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxValuationAllowanceProvisionalIncomeTaxExpenseBenefit
-138100000 USD
CY2017 cno Income Tax Expense Benefit Changein Valuation Allowancein Taxable Income
IncomeTaxExpenseBenefitChangeinValuationAllowanceinTaxableIncome
-15300000 USD
CY2019Q4 cno Loss Limitation Based On Income Of Life Insurance Company
LossLimitationBasedOnIncomeOfLifeInsuranceCompany
0.35
CY2019Q4 cno Loss Limitation Based On Loss Of Non Life Entities
LossLimitationBasedOnLossOfNonLifeEntities
0.35
CY2019Q4 cno Federal Long Term Tax Exempt Rate
FederalLongTermTaxExemptRate
0.0159
CY2019Q4 cno Ownership Change Threshold Restricting Net Operating Loss Usage
OwnershipChangeThresholdRestrictingNetOperatingLossUsage
0.50
CY2009Q4 cno Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void
OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid
0.05
CY2009Q1 cno Operating Loss Carryforward Limitation Numberof Rightsfor Each Share
OperatingLossCarryforwardLimitationNumberofRightsforEachShare
1 right
CY2009Q1 cno Ownership Percentage Threshold Relating To Company382 Securities
OwnershipPercentageThresholdRelatingToCompany382Securities
0.0499
CY2009Q1 cno Ownership Percentage Threshold Relating To Company382 Securities
OwnershipPercentageThresholdRelatingToCompany382Securities
0.0499
CY2010Q4 cno Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void
OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid
0.05
CY2010Q4 cno Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void
OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid
0.05
CY2019Q4 cno Nonoperating Loss Carryforwards
NonoperatingLossCarryforwards
2010900000 USD
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2534500000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
10300000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
14500000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019Q4 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
10900000 USD
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
8200000 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
989100000 USD
CY2018Q4 us-gaap Notes Payable
NotesPayable
916800000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7300000 USD
CY2019 cno Payment Of Redemption Premium
PaymentOfRedemptionPremium
6100000 USD
CY2019 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
1200000 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1000000000.0 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1000000000.0 USD
CY2019 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
LITIGATION AND OTHER LEGAL PROCEEDINGS<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Legal Proceedings</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and BCLIC commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against Beechwood Re Ltd. ("BRe") based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination.  In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP and its affiliates ("Platinum"). On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. On March 13, 2018, the District Court granted defendants' motion to compel arbitration of Washington National's and BCLIC's claims pending the outcome of the arbitration. In connection with the action brought by the PPCO Receiver, discussed below, BCLIC and Washington National reached agreements in October 2019 to settle all claims between themselves and the parties to the arbitration and litigation, namely BRe, Feuer, Taylor, Levy and Beechwood Capital Group, LLC. These settlements involve BCLIC’s and Washington National’s receipt of financial consideration and have been approved by the Grand Court of the Cayman Islands that is presiding over BRe’s winding up proceedings, as well as by the United States District Court for the Southern District of New York.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.  According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.  The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority.  On August 10, 2018, the Cayman Islands Monetary Authority filed a public petition in the Grand Court of the Cayman Islands to officially wind up BRe, concluding that BRe was now of doubtful solvency.  On November 27, 2018, the Grand Court of the Cayman Islands granted the petition to officially wind up BRe and appointed the current Controllers of BRe to be its Joint Official Liquidators. As noted in the previous paragraph, the Grand Court of the Cayman Islands has approved BRe’s settlements with BCLIC and Washington National.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 19, 2018, Melanie Cyganowski, as Equity Receiver for Platinum Partners Credit Opportunities Master Fund, LP ("PPCO") and other Platinum entities (the "PPCO Receiver") brought an action in the United States District Court for the Southern District of New York, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski v. Beechwood Re Ltd, et al.</span><span style="font-family:inherit;font-size:10pt;">, alleging, among other claims, fraud, aiding and abetting fraud, fraudulent transfer and violation of the Racketeer Influenced and Corrupt Organizations Act against numerous defendants, including BRe and many of its affiliates, CNO Financial Group, Inc., BCLIC, Washington National and 40|86 Advisors, Inc. The PPCO Receiver alleges that Platinum insiders conspired with BRe and its principals and affiliates in a massive fraudulent scheme to enrich the Platinum and BRe insiders to the detriment of Platinum investors and creditors. The PPCO Receiver alleges that CNO Financial Group, Inc., BCLIC, Washington National and 40|86 Advisors, Inc. have liability for the fraudulent scheme of the Platinum and BRe insiders under a theory that they turned a blind eye to the fraudulent scheme due to their desire to transfer unprofitable legacy portfolios of long-term care insurance via the reinsurance transactions with BRe. On January 24, 2019, the court consolidated the PPCO Receiver action with </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> other cases (to which the CNO companies are not parties) before it for at least discovery purposes.  On August 19, 2019, the court granted in their entirety CNO Financial Group, Inc.’s and 40|86 Advisors, Inc.’s motions to dismiss the PPCO Receiver’s claims against them. The court granted in part and denied in part the motions to dismiss of BCLIC and Washington National, dismissing the PPCO Receiver’s claims for, among other things, fraud, aiding and abetting fraud, securities fraud and violation of the Racketeer Influenced and Corrupt Organizations Act, while denying BCLIC’s and Washington National’s motions to dismiss the PPCO Receiver’s fraudulent transfer and unjust enrichment claims. BCLIC and Washington National have agreed with the PPCO </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receiver to fully settle the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski</span><span style="font-family:inherit;font-size:10pt;"> case and are preparing a settlement agreement for approval by the court. Under the settlement, neither BCLIC nor Washington National will incur any liability or make any payment to anyone, but instead they will be granted an allowed claim against PPCO’s estate.</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On March 27, 2019, BCLIC and Washington National brought cross-claims and third-party claims in the PPCO Receiver Action against BRe and a number of its affiliates, as well as many Platinum and BRe insiders, alleging that they secretly funded, controlled and operated the BRe enterprise for the benefit of Platinum.  BCLIC and Washington National have also brought third-party claims against Lincoln International LLC, which provided valuation services to the BRe enterprise. In October 2019, in exchange for their receiving financial consideration, BCLIC and Washington National agreed to settle many of their cross-claims and third-party claims against BRe and a number of its affiliates, as well as many Platinum and BRe insiders. BCLIC and Washington National have also resolved their claims against Lincoln International LLC. All of these settlements have been approved by the court.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On April 9, 2019, BCLIC and Washington National commenced an action entitled</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association</span><span style="font-family:inherit;font-size:10pt;">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action").  In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with BRe, as well as for breaching its fiduciary duties to BCLIC and Washington National.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, BCLIC, Washington National, 40|86 Advisors, Inc. and CNO Financial Group, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court.  Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities.  Plaintiffs contend that the Agera securities were fraudulently transferred to the Reinsurance Trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties.  The CNO Parties have removed the case to the United States District Court for the District of Delaware and are vigorously contesting the plaintiff's claims. Plaintiffs in this case have moved to remand the action back to Delaware Chancery Court. That motion remains pending.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 28, 2019, BCLIC and Washington National commenced an action entitled </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP</span><span style="font-family:inherit;font-size:10pt;">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action").  In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Regulatory Examinations and Fines</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </span><span style="font-family:inherit;font-size:10pt;"><span>41</span></span><span style="font-family:inherit;font-size:10pt;"> states and the District of Columbia participated in this examination. In November 2018, we entered into a Global Resolution Agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds. Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions will compare expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made. </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Guaranty Fund Assessments</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The balance sheet at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, included: (i) accruals of </span><span style="font-family:inherit;font-size:10pt;"><span>$8.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, representing our estimate of all known assessments that will be levied against the Company's insurance subsidiaries by various state guaranty associations based on premiums written through </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">; and (ii) receivables of </span><span style="font-family:inherit;font-size:10pt;"><span>$16.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> that we estimate will be recovered through a reduction in future premium taxes as a result of such assessments. At </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, such guaranty fund assessment accruals were </span><span style="font-family:inherit;font-size:10pt;"><span>$10.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> and such receivables were </span><span style="font-family:inherit;font-size:10pt;"><span>$18.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. These estimates are subject to change when the associations determine more precisely the losses that have occurred and how such losses will be allocated among the insurance companies. We recognized expense for such assessments of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$2.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Guarantees</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In accordance with the terms of the employment agreements of </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company's former chief executive officers, certain wholly-owned subsidiaries of the Company are the guarantors of the former executives' nonqualified supplemental retirement benefits. The liability for such benefits was </span><span style="font-family:inherit;font-size:10pt;"><span>$22.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$23.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively, and is included in the caption "Other liabilities" in the consolidated balance sheet.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Leases and Certain Other Long-Term Commitments</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company rents office space, equipment and computer software under contractual commitments or noncancellable operating lease agreements. In addition, the Company has entered into certain sponsorship agreements which require future payments. Total expense pursuant to these agreements was </span><span style="font-family:inherit;font-size:10pt;"><span>$67.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$67.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$61.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company rents office space for certain administrative operations of our Bankers Life segment under an agreement that expires in 2023. We lease sales offices in various states which are generally short-term in length with remaining lease terms expiring between 2020 and 2027. Many leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term only if the Company is reasonably certain of exercising those options. In determining the present value of lease payments, the Company uses its incremental borrowing rate for borrowings secured by collateral commensurate with the terms of the underlying lease. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Information related to our right of use assets are as follows (dollars in millions):</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:82%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for operating lease liability</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right of use assets obtained in exchange for lease liabilities (non-cash transactions)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total right of use assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Maturities of our operating lease liabilities as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> are as follows (dollars in millions):</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:61.40350877192983%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total undiscounted lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Present value of lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:61.40350877192983%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"/></tr><tr><td style="width:79%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.71</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>
CY2017Q3 cno Numberof Individuals Appointedto Assume Immediate Controland Power Over Affairs
NumberofIndividualsAppointedtoAssumeImmediateControlandPowerOverAffairs
2 individual
CY2011Q3 cno Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws
NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws
41 state
CY2019 us-gaap Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability
LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability
8900000 USD
CY2019Q4 us-gaap Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset
LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset
16800000 USD
CY2018 us-gaap Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability
LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability
10600000 USD
CY2018Q4 us-gaap Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset
LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset
18000000.0 USD
CY2019 cno Loss Contingency Insurance Related Assessment Expense Recognized
LossContingencyInsuranceRelatedAssessmentExpenseRecognized
2100000 USD
CY2018 cno Loss Contingency Insurance Related Assessment Expense Recognized
LossContingencyInsuranceRelatedAssessmentExpenseRecognized
2300000 USD
CY2017 cno Loss Contingency Insurance Related Assessment Expense Recognized
LossContingencyInsuranceRelatedAssessmentExpenseRecognized
11000000.0 USD
CY2019 cno Operating Leases And Sponsorship Agreements Expense
OperatingLeasesAndSponsorshipAgreementsExpense
67000000.0 USD
CY2018 cno Operating Leases And Sponsorship Agreements Expense
OperatingLeasesAndSponsorshipAgreementsExpense
67000000.0 USD
CY2017 cno Operating Leases And Sponsorship Agreements Expense
OperatingLeasesAndSponsorshipAgreementsExpense
61400000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
25000000.0 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
24300000 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22700000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66500000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
23900000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
19100000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
15500000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11400000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4300000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2000000.0 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
76200000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3700000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
72500000 USD
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0271
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6100000 USD
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5800000 USD
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5500000 USD
CY2019 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
74300000 USD
CY2018 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
59700000 USD
CY2017 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
190300000 USD
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
15400000 shares
CY2018 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
5500000 shares
CY2017 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
7800000 shares
CY2019 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
252300000 USD
CY2018 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
100900000 USD
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
167100000 USD
CY2019Q4 cno Stock Repurchase Program Remaining Repurchase Authorized Amount
StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount
532300000 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
67200000 USD
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.43
CY2018Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
65100000 USD
CY2018 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
59600000 USD
CY2017 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.09
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.09
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.08
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4700000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6539000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.77
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
801000 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.25
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
787000 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.95
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5500000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
538000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
19.32
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6015000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.59
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
38700000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3517000 shares
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M6D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25800000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4670000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5121000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2112000 shares
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.03
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
447000 shares
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.94
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3100000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
247000 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
20.29
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6539000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.77
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
44400000 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3247000 shares
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
26700000 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5296000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5354000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.73
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
729000 shares
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.06
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
237000 shares
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.81
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5200000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
725000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
11.43
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5121000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37200000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2440000 shares
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19200000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7488000 shares
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6900000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3900000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8300000 USD
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
6015000 shares
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
3517000 shares
CY2019Q4 cno Price Per One Thousandthof A Shareof Junior Preferred Stock
PricePerOneThousandthofAShareofJuniorPreferredStock
90.00
CY2019 cno Preferred Stock Purchase Right Rights Would Become Exercisableinthe Eventany Personor Group Becomes Ownerofa Stated Percentage Percentage
PreferredStockPurchaseRightRightsWouldBecomeExercisableintheEventanyPersonorGroupBecomesOwnerofaStatedPercentagePercentage
0.0499
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
409400000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-315000000.0 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
175600000 USD
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156040000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165457000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170025000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1108000 shares
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2119000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157148000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165457000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172144000 shares
CY2018 cno Common Stock Shares Excluded From Diluted Weighted Average Shares Outstanding
CommonStockSharesExcludedFromDilutedWeightedAverageSharesOutstanding
2104000 shares
CY2019 us-gaap Direct Premiums Written
DirectPremiumsWritten
4311900000 USD
CY2018 us-gaap Direct Premiums Written
DirectPremiumsWritten
4150300000 USD
CY2017 us-gaap Direct Premiums Written
DirectPremiumsWritten
4013400000 USD
CY2019 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
25100000 USD
CY2018 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
27800000 USD
CY2017 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
30200000 USD
CY2019 us-gaap Ceded Premiums Earned
CededPremiumsEarned
267900000 USD
CY2018 us-gaap Ceded Premiums Earned
CededPremiumsEarned
156200000 USD
CY2017 us-gaap Ceded Premiums Earned
CededPremiumsEarned
114400000 USD
CY2019 us-gaap Premiums Written Net
PremiumsWrittenNet
4069100000 USD
CY2018 us-gaap Premiums Written Net
PremiumsWrittenNet
4021900000 USD
CY2017 us-gaap Premiums Written Net
PremiumsWrittenNet
3929200000 USD
CY2019 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
7500000 USD
CY2018 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-6500000 USD
CY2017 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-19000000.0 USD
CY2019 cno Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities
PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities
1743100000 USD
CY2018 cno Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities
PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities
1588500000 USD
CY2017 cno Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities
PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities
1445900000 USD
CY2019 cno Premiums Earned Traditional Products With Mortality Or Morbidity Risk
PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk
2318500000 USD
CY2018 cno Premiums Earned Traditional Products With Mortality Or Morbidity Risk
PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk
2439900000 USD
CY2017 cno Premiums Earned Traditional Products With Mortality Or Morbidity Risk
PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk
2502300000 USD
CY2019 cno Fees And Surrender Charges On Interest Sensitive Products
FeesAndSurrenderChargesOnInterestSensitiveProducts
162300000 USD
CY2018 cno Fees And Surrender Charges On Interest Sensitive Products
FeesAndSurrenderChargesOnInterestSensitiveProducts
153200000 USD
CY2017 cno Fees And Surrender Charges On Interest Sensitive Products
FeesAndSurrenderChargesOnInterestSensitiveProducts
145000000.0 USD
CY2019 us-gaap Premiums Earned Net
PremiumsEarnedNet
2480800000 USD
CY2018 us-gaap Premiums Earned Net
PremiumsEarnedNet
2593100000 USD
CY2017 us-gaap Premiums Earned Net
PremiumsEarnedNet
2647300000 USD
CY2019Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
3 state
CY2019 us-gaap Insurance Commissions
InsuranceCommissions
133600000 USD
CY2018 us-gaap Insurance Commissions
InsuranceCommissions
122800000 USD
CY2017 us-gaap Insurance Commissions
InsuranceCommissions
115600000 USD
CY2019 cno Salaries Wages And Officers Compensation Including Share Based Compensation
SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation
238200000 USD
CY2018 cno Salaries Wages And Officers Compensation Including Share Based Compensation
SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation
233200000 USD
CY2017 cno Salaries Wages And Officers Compensation Including Share Based Compensation
SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation
237300000 USD
CY2019 cno Operating Costs And Expenses Other
OperatingCostsAndExpensesOther
561100000 USD
CY2018 cno Operating Costs And Expenses Other
OperatingCostsAndExpensesOther
458200000 USD
CY2017 cno Operating Costs And Expenses Other
OperatingCostsAndExpensesOther
488600000 USD
CY2019 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
932900000 USD
CY2018 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
814200000 USD
CY2017 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
841500000 USD
CY2018Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1322500000 USD
CY2017Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1026800000 USD
CY2016Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1044700000 USD
CY2019 us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
288700000 USD
CY2018 us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
261800000 USD
CY2017 us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
236100000 USD
CY2019 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
195400000 USD
CY2018 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
219200000 USD
CY2017 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
184900000 USD
CY2019 cno Deferred Policy Acquisition Cost Effect Of Reinsurance Transactions
DeferredPolicyAcquisitionCostEffectOfReinsuranceTransactions
0 USD
CY2018 cno Deferred Policy Acquisition Cost Effect Of Reinsurance Transactions
DeferredPolicyAcquisitionCostEffectOfReinsuranceTransactions
-1200000 USD
CY2017 cno Deferred Policy Acquisition Cost Effect Of Reinsurance Transactions
DeferredPolicyAcquisitionCostEffectOfReinsuranceTransactions
0 USD
CY2019 cno Deferred Policy Acquisition Cost Unrealized Investment Gains Losses
DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses
-189600000 USD
CY2018 cno Deferred Policy Acquisition Cost Unrealized Investment Gains Losses
DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses
254300000 USD
CY2017 cno Deferred Policy Acquisition Cost Unrealized Investment Gains Losses
DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses
-69100000 USD
CY2019 cno Deferred Policy Acquisition Costs Other Adjustments
DeferredPolicyAcquisitionCostsOtherAdjustments
-10700000 USD
CY2018 cno Deferred Policy Acquisition Costs Other Adjustments
DeferredPolicyAcquisitionCostsOtherAdjustments
0 USD
CY2017 cno Deferred Policy Acquisition Costs Other Adjustments
DeferredPolicyAcquisitionCostsOtherAdjustments
0 USD
CY2019Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1215500000 USD
CY2018Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1322500000 USD
CY2017Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1026800000 USD
CY2018Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
343600000 USD
CY2017Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
359600000 USD
CY2016Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
401800000 USD
CY2019 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
36700000 USD
CY2018 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
45100000 USD
CY2017 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
54400000 USD
CY2019 cno Present Value Of Future Insurance Profits Effect Of Reinsurance Transactions
PresentValueOfFutureInsuranceProfitsEffectOfReinsuranceTransactions
0 USD
CY2018 cno Present Value Of Future Insurance Profits Effect Of Reinsurance Transactions
PresentValueOfFutureInsuranceProfitsEffectOfReinsuranceTransactions
-60400000 USD
CY2017 cno Present Value Of Future Insurance Profits Effect Of Reinsurance Transactions
PresentValueOfFutureInsuranceProfitsEffectOfReinsuranceTransactions
0 USD
CY2019 us-gaap Present Value Of Future Insurance Profits Period Increase Decrease
PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease
-14400000 USD
CY2018 us-gaap Present Value Of Future Insurance Profits Period Increase Decrease
PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease
89500000 USD
CY2017 us-gaap Present Value Of Future Insurance Profits Period Increase Decrease
PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease
12200000 USD
CY2019 cno Present Valueof Future Profit Other Adjustments
PresentValueofFutureProfitOtherAdjustments
-17100000 USD
CY2018 cno Present Valueof Future Profit Other Adjustments
PresentValueofFutureProfitOtherAdjustments
0 USD
CY2017 cno Present Valueof Future Profit Other Adjustments
PresentValueofFutureProfitOtherAdjustments
0 USD
CY2019Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
275400000 USD
CY2018Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
343600000 USD
CY2017Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
359600000 USD
CY2019Q4 us-gaap Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year One
PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearOne
0.11
CY2019Q4 us-gaap Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Two
PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearTwo
0.09
CY2019Q4 us-gaap Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Three
PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearThree
0.08
CY2019Q4 us-gaap Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Four
PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearFour
0.07
CY2019Q4 us-gaap Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Five
PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearFive
0.07
CY2019 us-gaap Net Income Loss
NetIncomeLoss
409400000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-315000000.0 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
267900000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
292200000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
265400000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-132800000 USD
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
18400000 USD
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
227500000 USD
CY2019 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
632400000 USD
CY2018 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
207800000 USD
CY2017 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
464700000 USD
CY2019 cno Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments
ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments
-240700000 USD
CY2018 cno Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments
ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments
14900000 USD
CY2017 cno Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments
ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments
-294900000 USD
CY2019 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
288700000 USD
CY2018 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
261700000 USD
CY2017 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
236100000 USD
CY2019 cno Gain Losson Investments Excluding Cash Expenses
GainLossonInvestmentsExcludingCashExpenses
28200000 USD
CY2018 cno Gain Losson Investments Excluding Cash Expenses
GainLossonInvestmentsExcludingCashExpenses
-11300000 USD
CY2017 cno Gain Losson Investments Excluding Cash Expenses
GainLossonInvestmentsExcludingCashExpenses
50300000 USD
CY2019 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses
0 USD
CY2018 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses
363400000 USD
CY2017 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses
0 USD
CY2019 cno Gain Losson Disposal Group Gain Losson Reinsurance Transactionsand Transition Expenses
GainLossonDisposalGroupGainLossonReinsuranceTransactionsandTransitionExpenses
0 USD
CY2018 cno Gain Losson Disposal Group Gain Losson Reinsurance Transactionsand Transition Expenses
GainLossonDisposalGroupGainLossonReinsuranceTransactionsandTransitionExpenses
-1067600000 USD
CY2017 cno Gain Losson Disposal Group Gain Losson Reinsurance Transactionsand Transition Expenses
GainLossonDisposalGroupGainLossonReinsuranceTransactionsandTransitionExpenses
0 USD
CY2019 cno Payment To Reinsurer Pursuant To Long Term Care Business Reinsured
PaymentToReinsurerPursuantToLongTermCareBusinessReinsured
0 USD
CY2018 cno Payment To Reinsurer Pursuant To Long Term Care Business Reinsured
PaymentToReinsurerPursuantToLongTermCareBusinessReinsured
365000000.0 USD
CY2017 cno Payment To Reinsurer Pursuant To Long Term Care Business Reinsured
PaymentToReinsurerPursuantToLongTermCareBusinessReinsured
0 USD
CY2019 cno Gain Loss On Extinguishment Of Debt Variable Interest Entities
GainLossOnExtinguishmentOfDebtVariableInterestEntities
0 USD
CY2018 cno Gain Loss On Extinguishment Of Debt Variable Interest Entities
GainLossOnExtinguishmentOfDebtVariableInterestEntities
-3800000 USD
CY2017 cno Gain Loss On Extinguishment Of Debt Variable Interest Entities
GainLossOnExtinguishmentOfDebtVariableInterestEntities
-9500000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7300000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
70100000 USD
CY2018 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
6900000 USD
CY2017 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
71900000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
696700000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
317800000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
633300000 USD
CY2018Q3 cno Reinsurance Investments Transferred
ReinsuranceInvestmentsTransferred
3582100000 USD
CY2018Q3 cno Cash Paid To Reinsurer
CashPaidToReinsurer
365000000.0 USD
CY2018Q3 cno Reinsurance Accrued Interest On Investments Transferred
ReinsuranceAccruedInterestOnInvestmentsTransferred
51600000 USD
CY2018Q3 cno Reinsurance Present Value Of Future Profits And Deferred Acquisition Costs Writtenoff
ReinsurancePresentValueOfFutureProfitsAndDeferredAcquisitionCostsWrittenoff
61600000 USD
CY2018Q3 cno Reinsurance Receivables Payables
ReinsuranceReceivablesPayables
-2818000000.0 USD
CY2018Q3 cno Transaction Expenses And Other
TransactionExpensesAndOther
14600000 USD
CY2018Q3 cno Reinsurance Release Of Future Loss Reserve
ReinsuranceReleaseOfFutureLossReserve
-189300000 USD
CY2018Q3 cno Reinsurance Transaction Total Impact
ReinsuranceTransactionTotalImpact
1067600000 USD
CY2018Q3 cno Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction
NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction
363400000 USD
CY2018Q3 cno Reinsurance Pretax Gain Loss
ReinsurancePretaxGainLoss
-704200000 USD
CY2019 cno Share Based Compensation Noncash Portion
ShareBasedCompensationNoncashPortion
19300000 USD
CY2018 cno Share Based Compensation Noncash Portion
ShareBasedCompensationNoncashPortion
24700000 USD
CY2017 cno Share Based Compensation Noncash Portion
ShareBasedCompensationNoncashPortion
21400000 USD
CY2019Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
1696600000 USD
CY2018Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
1652800000 USD
CY2019Q4 cno Statutory Accounting Practices Statutory Asset Valuation Reserve
StatutoryAccountingPracticesStatutoryAssetValuationReserve
295900000 USD
CY2018Q4 cno Statutory Accounting Practices Statutory Asset Valuation Reserve
StatutoryAccountingPracticesStatutoryAssetValuationReserve
233300000 USD
CY2019Q4 cno Statutory Accounting Practices Statutory Interest Maintenance Reserve
StatutoryAccountingPracticesStatutoryInterestMaintenanceReserve
420100000 USD
CY2018Q4 cno Statutory Accounting Practices Statutory Interest Maintenance Reserve
StatutoryAccountingPracticesStatutoryInterestMaintenanceReserve
425000000.0 USD
CY2019Q4 cno Statutory Capital And Surplus Asset Valuation Reserve Interest Maintenance Reserve Total
StatutoryCapitalAndSurplusAssetValuationReserveInterestMaintenanceReserveTotal
2412600000 USD
CY2018Q4 cno Statutory Capital And Surplus Asset Valuation Reserve Interest Maintenance Reserve Total
StatutoryCapitalAndSurplusAssetValuationReserveInterestMaintenanceReserveTotal
2311100000 USD
CY2019Q4 cno Investments In Upstream Affiliates Included In Statutory Capital And Surplus
InvestmentsInUpstreamAffiliatesIncludedInStatutoryCapitalAndSurplus
42600000 USD
CY2019 us-gaap Statutory Accounting Practices Statutory Net Income Amount
StatutoryAccountingPracticesStatutoryNetIncomeAmount
291400000 USD
CY2018 us-gaap Statutory Accounting Practices Statutory Net Income Amount
StatutoryAccountingPracticesStatutoryNetIncomeAmount
-293300000 USD
CY2018 cno Statutory Accounting Practices Loss Related To Reinsurance Transaction
StatutoryAccountingPracticesLossRelatedToReinsuranceTransaction
541000000 USD
CY2017 us-gaap Statutory Accounting Practices Statutory Net Income Amount
StatutoryAccountingPracticesStatutoryNetIncomeAmount
352300000 USD
CY2019 cno Statutory Accounting Practices Income Tax Expense Benefit
StatutoryAccountingPracticesIncomeTaxExpenseBenefit
-46000000.0 USD
CY2019Q4 us-gaap Statutory Accounting Practices Statutory Amount Available For Dividend Payments
StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments
46000000.0 USD
CY2019 cno Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income
StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome
-16600000 USD
CY2018 cno Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income
StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome
43800000 USD
CY2017 cno Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income
StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome
-9900000 USD
CY2019 cno Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income
StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome
166300000 USD
CY2018 cno Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income
StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome
159200000 USD
CY2017 cno Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income
StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome
158300000 USD
CY2019Q4 cno Percentage Of Statutory Capital And Surplus Available For Dividend Distribution Without Prior Approval From Regulatory Agency
PercentageOfStatutoryCapitalAndSurplusAvailableForDividendDistributionWithoutPriorApprovalFromRegulatoryAgency
0.10
CY2019 cno Amountof Dividends Paid By Insurance Subsidiaries
AmountofDividendsPaidByInsuranceSubsidiaries
186300000 USD
CY2019Q4 us-gaap Statutory Accounting Practices Statutory Amount Available For Dividend Payments
StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments
46000000.0 USD
CY2019Q4 cno Trended Adjusted Capitalto Riskbased Capital Ratio Threshold
TrendedAdjustedCapitaltoRiskbasedCapitalRatioThreshold
0.95
CY2019 cno Revenues Excluding Realized Gains Losses
RevenuesExcludingRealizedGainsLosses
3910500000 USD
CY2018 cno Revenues Excluding Realized Gains Losses
RevenuesExcludingRealizedGainsLosses
3888800000 USD
CY2017 cno Revenues Excluding Realized Gains Losses
RevenuesExcludingRealizedGainsLosses
4194200000 USD
CY2019 cno Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes
BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes
3542200000 USD
CY2018 cno Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes
BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes
3507600000 USD
CY2017 cno Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes
BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes
3739500000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
368300000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
381200000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
454700000 USD
CY2019 us-gaap Revenues
Revenues
4015800000 USD
CY2018 us-gaap Revenues
Revenues
4313500000 USD
CY2017 us-gaap Revenues
Revenues
4297200000 USD
CY2019 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
3741600000 USD
CY2018 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
4578300000 USD
CY2017 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
3816700000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
274200000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-264800000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
480500000 USD
CY2019 cno Income Tax Expense Benefit Before Valuation Allowance Adjustment
IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment
58500000 USD
CY2018 cno Income Tax Expense Benefit Before Valuation Allowance Adjustment
IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment
-57600000 USD
CY2017 cno Income Tax Expense Benefit Before Valuation Allowance Adjustment
IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment
162800000 USD
CY2019 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-193700000 USD
CY2018 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
107800000 USD
CY2017 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
142100000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
409400000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-315000000.0 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2019Q4 us-gaap Assets
Assets
33630900000 USD
CY2018Q4 us-gaap Assets
Assets
31439800000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
28953900000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
28068900000 USD
CY2019Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
275400000 USD
CY2019Q4 us-gaap Supplementary Insurance Information Deferred Policy Acquisition Costs
SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts
1215500000 USD
CY2019Q4 cno Insurance Liabilities
InsuranceLiabilities
24417800000 USD
CY2018Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
343600000 USD
CY2018Q4 us-gaap Supplementary Insurance Information Deferred Policy Acquisition Costs
SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts
1322500000 USD
CY2018Q4 cno Insurance Liabilities
InsuranceLiabilities
23456700000 USD
CY2019Q1 us-gaap Revenues
Revenues
1023000000.0 USD
CY2019Q2 us-gaap Revenues
Revenues
979800000 USD
CY2019Q3 us-gaap Revenues
Revenues
944000000.0 USD
CY2019Q4 us-gaap Revenues
Revenues
1069000000.0 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
65600000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47700000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
53500000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
107400000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10100000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11500000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-170600000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
51800000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
37600000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
42000000.0 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
278000000.0 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.85
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.84
CY2018Q1 us-gaap Revenues
Revenues
1007800000 USD
CY2018Q2 us-gaap Revenues
Revenues
1046300000 USD
CY2018Q3 us-gaap Revenues
Revenues
1481200000 USD
CY2018Q4 us-gaap Revenues
Revenues
778200000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
108100000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
129800000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-539800000 USD
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37100000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23800000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27600000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10000000.0 USD
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8800000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
84300000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
102200000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-529800000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
28300000 USD
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.22
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.22
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2019 cno Variable Interest Entity Realized Gain Loss On Sale Of Investments Related To Dissolution
VariableInterestEntityRealizedGainLossOnSaleOfInvestmentsRelatedToDissolution
-5100000 USD
CY2017 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
-4300000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2020
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2020
2100000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2021
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2021
27600000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2022
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2022
99700000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2023
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2023
340500000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2024
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2024
314100000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2025
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2025
183300000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2026
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2026
120100000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2027
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2027
63400000 USD
CY2019Q4 cno Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2028
RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2028
800000 USD
CY2019Q4 cno Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2030
RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2030
7000000.0 USD
CY2019Q4 cno Variable Interest Entity Amortized Cost Securities Held
VariableInterestEntityAmortizedCostSecuritiesHeld
1206300000 USD
CY2019Q4 cno Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities
VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities
3900000 USD
CY2019Q4 cno Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities
VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities
-21600000 USD
CY2019Q4 cno Variable Interest Entity Fixed Maturity Securities Fair Value
VariableInterestEntityFixedMaturitySecuritiesFairValue
1188600000 USD
CY2019 cno Variable Interest Entities Net Realized Gain Loss On Investments
VariableInterestEntitiesNetRealizedGainLossOnInvestments
20500000 USD
CY2019 cno Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments
VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments
-12400000 USD
CY2019 cno Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities
TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities
3000000.0 USD
CY2018 cno Variable Interest Entities Net Realized Gain Loss On Investments
VariableInterestEntitiesNetRealizedGainLossOnInvestments
3600000 USD
CY2017 cno Variable Interest Entities Net Realized Gain Loss On Investments
VariableInterestEntitiesNetRealizedGainLossOnInvestments
5600000 USD
CY2017 cno Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments
VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments
1200000 USD
CY2017 cno Variable Interest Entity Gain Losson Dissolution
VariableInterestEntityGainLossonDissolution
-4300000 USD
CY2017 cno Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities
TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities
2500000 USD
CY2019Q4 cno Numberof Variable Interest Entitiesin Default
NumberofVariableInterestEntitiesinDefault
1 entity
CY2019 cno Variable Interest Entities Investments Sold
VariableInterestEntitiesInvestmentsSold
280600000 USD
CY2019 cno Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax
VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax
12600000 USD
CY2018 cno Variable Interest Entities Investments Sold
VariableInterestEntitiesInvestmentsSold
57200000 USD
CY2018 cno Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax
VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax
3800000 USD
CY2017 cno Variable Interest Entities Investments Sold
VariableInterestEntitiesInvestmentsSold
109600000 USD
CY2017 cno Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax
VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax
3000000.0 USD
CY2019Q4 cno One Time Charge Related To New Operating Model And It Partnership
OneTimeChargeRelatedToNewOperatingModelAndITPartnership
14000000 USD

Files In Submission

Name View Source Status
0001224608-20-000009-index-headers.html Edgar Link pending
0001224608-20-000009-index.html Edgar Link pending
0001224608-20-000009.txt Edgar Link pending
0001224608-20-000009-xbrl.zip Edgar Link pending
cno-20191231.xsd Edgar Link pending
cno-20191231_cal.xml Edgar Link unprocessable
cno-20191231_def.xml Edgar Link unprocessable
cno-20191231_lab.xml Edgar Link unprocessable
cno-20191231_pre.xml Edgar Link unprocessable
cno1231201910-k.htm Edgar Link pending
cno1231201910-k_htm.xml Edgar Link completed
cno12312019ex21.htm Edgar Link pending
cno12312019ex231.htm Edgar Link pending
cno12312019ex311.htm Edgar Link pending
cno12312019ex312.htm Edgar Link pending
cno12312019ex321.htm Edgar Link pending
cno12312019ex322.htm Edgar Link pending
cno12312019ex49.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orgchart2019.jpg Edgar Link pending
performance2019.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R129.htm Edgar Link pending
R13.htm Edgar Link pending
R130.htm Edgar Link pending
R131.htm Edgar Link pending
R132.htm Edgar Link pending
R133.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending